Genetic variations and polymorphisms of G protein-coupled receptors: functional and therapeutic implications.
暂无分享,去创建一个
[1] Gert Vriend,et al. GPCRDB information system for G protein-coupled receptors , 2003, Nucleic Acids Res..
[2] D. O'Connor,et al. β2-Adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans. , 2000 .
[3] M. Bouvier,et al. Export from the Endoplasmic Reticulum Represents the Limiting Step in the Maturation and Cell Surface Expression of the Human δ Opioid Receptor* , 2000, The Journal of Biological Chemistry.
[4] R. Leurs,et al. The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor. , 2000, Molecular pharmacology.
[5] U. Kumar,et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. , 2000, Science.
[6] S. Angers,et al. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. , 2000, The Journal of clinical investigation.
[7] M. R. Adams,et al. Comparative genomics of the eukaryotes. , 2000, Science.
[8] P. Goldman-Rakic,et al. Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. , 2000, Science.
[9] S. Liggett. β2-Adrenergic Receptor Pharmacogenetics , 2000 .
[10] A. Schonbrunn,et al. Protein Kinase C Activation Stimulates the Phosphorylation and Internalization of the sst2A Somatostatin Receptor* , 2000, The Journal of Biological Chemistry.
[11] A. Scheer,et al. Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: effects on receptor isomerization and activation. , 2000, Molecular pharmacology.
[12] U. Gether. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.
[13] Z. Vogel,et al. Role of the highly conserved Asp‐Arg‐Tyr motif in signal transduction of the CB2 cannabinoid receptor , 2000, FEBS letters.
[14] R. Hermosilla,et al. The role of conserved extracellular cysteine residues in vasopressin V2 receptor function and properties of two naturally occurring mutant receptors with additional extracellular cysteine residues , 2000, FEBS letters.
[15] J. Mollon,et al. A cluster of single nucleotide polymorphisms in the 5′-leader of the human dopamine D3 receptor gene (DRD3) and its relationship to schizophrenia , 2000, Neuroscience Letters.
[16] T Fenyvesi,et al. Angiotensin II type 1 receptor gene polymorphism and mitral valve prolapse syndrome. , 2000, American heart journal.
[17] S. Liggett. beta(2)-adrenergic receptor pharmacogenetics. , 2000, American journal of respiratory and critical care medicine.
[18] Qing Yang,et al. Expression and Function of the Gonadotropin-releasing Hormone Receptor Are Dependent on a Conserved Apolar Amino Acid in the Third Intracellular Loop* , 1999, The Journal of Biological Chemistry.
[19] K. Thai,et al. Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II. , 1999, Kidney international.
[20] M. Polak. Hyperfunctioning thyroid adenoma and activating mutations in the TSH receptor gene. , 1999, Archives of medical research.
[21] Liaoyuan A. Hu,et al. Identification of the endophilins (SH3p4/p8/p13) as novel binding partners for the beta1-adrenergic receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[22] R. Hubbard,et al. Association of CCR5 ▵32 with reduced risk of asthma , 1999, The Lancet.
[23] D StClair,et al. -141 C del/ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population. , 1999, American journal of medical genetics.
[24] Emmanuel Mignot,et al. The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene , 1999, Cell.
[25] Jon T. Willie,et al. Narcolepsy in orexin Knockout Mice Molecular Genetics of Sleep Regulation , 1999, Cell.
[26] P Ghanouni,et al. Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6. , 1999, Molecular pharmacology.
[27] M. Parmentier,et al. Human P2Y2 receptor polymorphism: identification and pharmacological characterization of two allelic variants , 1999, British journal of pharmacology.
[28] F Skrabal,et al. beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. , 1999, Hypertension.
[29] R. Detels,et al. Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: absence of mutation among Asians and Pacific Islanders. , 1999, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[30] Thomas Gudermann,et al. Structural basis of G protein-coupled receptor function , 1999, Molecular and Cellular Endocrinology.
[31] Kenneth A. Jacobson,et al. The Role of Amino Acids in Extracellular Loops of the Human P2Y1 Receptor in Surface Expression and Activation Processes* , 1999, The Journal of Biological Chemistry.
[32] T. Arinami,et al. A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. , 1999, Biochemical and biophysical research communications.
[33] K. Palczewski,et al. β-Arrestin-dependent Desensitization of Luteinizing Hormone/Choriogonadotropin Receptor Is Prevented by a Synthetic Peptide Corresponding to the Third Intracellular Loop of the Receptor* , 1999, The Journal of Biological Chemistry.
[34] D. Thomason,et al. Impact of genetic polymorphisms of the β2‐adrenergic receptor on albuterol bronchodilator pharmacodynamics , 1999, Clinical pharmacology and therapeutics.
[35] A. Koyanagi,et al. Polymorphism in the 5'-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes. , 1999, The Journal of clinical endocrinology and metabolism.
[36] J. Bockaert,et al. Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain. , 1999, Molecular pharmacology.
[37] D. A. Mason,et al. A Gain-of-function Polymorphism in a G-protein Coupling Domain of the Human β1-Adrenergic Receptor* , 1999, The Journal of Biological Chemistry.
[38] Colleen M. Niswender,et al. RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity* , 1999, The Journal of Biological Chemistry.
[39] J. Bockaert,et al. Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.
[40] D. Hewett‐Emmett,et al. High polymorphism at the human melanocortin 1 receptor locus. , 1999, Genetics.
[41] P. Insel,et al. Human adrenoceptor polymorphisms: evolving recognition of clinical importance. , 1999, Trends in pharmacological sciences.
[42] I. Hall,et al. β2-Adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting β2-agonist therapy , 1999 .
[43] K. Ohara,et al. Schizophrenia and the serotonin-2A receptor promoter polymorphism , 1999, Psychiatry Research.
[44] I. Hall,et al. Effects of genetic polymorphism on ex vivo and in vivo function of beta2-adrenoceptors in asthmatic patients. , 1999, Chest.
[45] I. Hall,et al. Identification of novel polymorphisms within the promoter region of the human β2 adrenergic receptor gene , 1999, British journal of pharmacology.
[46] M. Caron,et al. Constitutively active alpha-1b adrenergic receptor mutants display different phosphorylation and internalization features. , 1999, Molecular pharmacology.
[47] I. Hall,et al. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy. , 1999, Clinical science.
[48] R. Hubbard,et al. Association of CCR5 delta32 with reduced risk of asthma. , 1999, Lancet.
[49] J. Haines,et al. Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals. , 1999, Pharmacogenetics.
[50] Y. Totsuka,et al. A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia. , 1999, The Journal of clinical endocrinology and metabolism.
[51] E. Fleck,et al. Screening the human bradykinin B2 receptor gene in patients with cardiovascular diseases: identification of a functional mutation in the promoter and a new coding variant (T21M). , 1998, American journal of medical genetics.
[52] Cori Bargmann. Neurobiology of the Caenorhabditis elegans genome. , 1998, Science.
[53] J. Wess,et al. Molecular basis of receptor/G-protein-coupling selectivity. , 1998, Pharmacology & therapeutics.
[54] S. Liggett,et al. Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression. , 1998, The Journal of clinical investigation.
[55] J. Bockaert,et al. 5‐HT4 Receptors: Gene, Transduction and Effects on Olfactory Memory , 1998, Annals of the New York Academy of Sciences.
[56] T. Pawson,et al. SH3 binding domains in the dopamine D4 receptor. , 1998, Biochemistry.
[57] N. Cotte,et al. Identification of Residues Responsible for the Selective Binding of Peptide Antagonists and Agonists in the V2 Vasopressin Receptor* , 1998, The Journal of Biological Chemistry.
[58] V. Álvarez,et al. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease. , 1998, Cardiovascular research.
[59] K. Clément,et al. A frameshift mutation in human MC4R is associated with a dominant form of obesity , 1998, Nature Genetics.
[60] S. O’Rahilly,et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity , 1998, Nature Genetics.
[61] C. Kleeberger,et al. CCR5 promoter polymorphism and HIV-1 disease progression , 1998, The Lancet.
[62] E. Brown,et al. Dimerization of the Extracellular Calcium-sensing Receptor (CaR) on the Cell Surface of CaR-transfected HEK293 Cells* , 1998, The Journal of Biological Chemistry.
[63] D. Bikle,et al. The Calcium Sensing Receptor and Its Alternatively Spliced Form in Keratinocyte Differentiation* , 1998, The Journal of Biological Chemistry.
[64] J A Tischfield,et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[65] Robert J. Lefkowitz,et al. G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[66] B. Kobilka,et al. G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[67] M. Grossmann,et al. G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[68] E. Brown,et al. Familial hypoparathyroidism: identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor. , 1998, The Journal of clinical endocrinology and metabolism.
[69] T. Wienker,et al. Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. , 1998, Kidney international.
[70] M. Yanagisawa,et al. Novel Mutations of the Endothelin B Receptor Gene in Patients with Hirschsprung’s Disease and Their Characterization* , 1998, The Journal of Biological Chemistry.
[71] W. Rosenthal,et al. The molecular basis of nephrogenic diabetes insipidus , 1998, Journal of Molecular Medicine.
[72] J. Friedman,et al. Desensitization of β2-Adrenergic Receptors with Mutations of the Proposed G Protein-coupled Receptor Kinase Phosphorylation Sites* , 1998, The Journal of Biological Chemistry.
[73] K. Kameyama,et al. Internalization and Down-regulation of Human Muscarinic Acetylcholine Receptor m2 Subtypes , 1998, The Journal of Biological Chemistry.
[74] L. Romics,et al. Association of angiotensin II type 1 receptor polymorphism with resistant essential hypertension. , 1998, Clinica chimica acta; international journal of clinical chemistry.
[75] H. V. Van Tol. Structural and functional characteristics of the dopamine D4 receptor. , 1998, Advances in pharmacology.
[76] M. Birnbaumer,et al. Mutations of the DRY motif that preserve beta 2-adrenoceptor coupling. , 1998, Receptors & channels.
[77] M. Bouvier,et al. Structural and functional aspects of G protein-coupled receptor oligomerization. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[78] D. Collier,et al. Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine , 1998, Molecular Psychiatry.
[79] R. Erickson,et al. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. , 1997, The Journal of clinical investigation.
[80] R. Paschke,et al. Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters. , 1997, The Journal of clinical endocrinology and metabolism.
[81] L. Devi,et al. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.
[82] Marc Parmentier,et al. The Second Extracellular Loop of CCR5 Is the Major Determinant of Ligand Specificity* , 1997, The Journal of Biological Chemistry.
[83] M. Caulfield,et al. Essential hypertension in African Caribbeans associates with a variant of the beta2-adrenoceptor. , 1997, Hypertension.
[84] N. Martin,et al. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. , 1997, Human molecular genetics.
[85] I. Gantz,et al. Molecular Basis for the Interaction of [Nle4,d-Phe7]Melanocyte Stimulating Hormone with the Human Melanocortin-1 Receptor (Melanocyte α-MSH Receptor)* , 1997, The Journal of Biological Chemistry.
[86] Tao Li,et al. Association between 5-HT2A gene promoter polymorphism and anorexia nervosa , 1997, The Lancet.
[87] K. Ray,et al. Sporadic hypoparathyroidism caused by de Novo gain-of-function mutations of the Ca(2+)-sensing receptor. , 1997, The Journal of clinical endocrinology and metabolism.
[88] K. Eidne,et al. An intramolecular disulfide bond between conserved extracellular cysteines in the gonadotropin-releasing hormone receptor is essential for binding and activation. , 1997, Endocrinology.
[89] D. Goldman,et al. Agonist-Promoted Down-Regulation and Functional Desensitization in Two Naturally Occurring Variants of the Human Serotonin1A Receptor , 1997, Neuropsychopharmacology.
[90] P. Seeburg,et al. Interaction of ion channels and receptors with PDZ domain proteins , 1997, Current Opinion in Neurobiology.
[91] P. Insel,et al. Decreased transcript expression coincident with impaired glycosylation in the beta2-adrenergic receptor gene does not result from differences in the primary sequence. , 1997, Biochimica et biophysica acta.
[92] M. Kozak,et al. Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6 , 1997, The EMBO journal.
[93] M. Nöthen,et al. Human 5-HT5AReceptor Gene: Systematic Screening for DNA Sequence Variation and Linkage Mapping on Chromosome 7q34–q36 Using a Polymorphism in the 5′ Untranslated Region , 1997 .
[94] T. Arinami,et al. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. , 1997, Human molecular genetics.
[95] R. Scully,et al. A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors. , 1997, The Journal of clinical endocrinology and metabolism.
[96] C. Barnes,et al. Homer: a protein that selectively binds metabotropic glutamate receptors , 1997, Nature.
[97] B. Morris,et al. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension , 1997, Clinical genetics.
[98] H. V. Van Tol,et al. Structural and Functional Characteristics of the Dopamine D4 Receptor , 1997 .
[99] M. Nöthen,et al. Human 5-HT5A receptor gene: systematic screening for DNA sequence variation and linkage mapping on chromosome 7q34-q36 using a polymorphism in the 5' untranslated region. , 1997, Biochemical and biophysical research communications.
[100] E. Brown,et al. In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. , 1997, The Journal of clinical investigation.
[101] R. Devés,et al. Changes in Membrane and Surface Potential Explain the Opposite Effects of Low Ionic Strength on the Two Lysine Transporters of Human Erythrocytes* , 1996, The Journal of Biological Chemistry.
[102] A. Couvineau,et al. Receptors for VIP, PACAP, Secretin, GRF, Glucagon, GLP‐1, and Other Members of Their New Family of G Protein‐Linked Receptors: Structure‐Function Relationship with Special Reference to the Human VIP‐1 Receptor a , 1996, Annals of the New York Academy of Sciences.
[103] D. Sibley,et al. Functional Analysis of the Human D2 Dopamine Receptor Missense Variants* , 1996, The Journal of Biological Chemistry.
[104] S. Karnik,et al. Modulation of GDP Release from Transducin by the Conserved Glu134-Arg135 Sequence in Rhodopsin* , 1996, The Journal of Biological Chemistry.
[105] N. Elshourbagy,et al. Molecular Characterization of a Novel Human Endothelin Receptor Splice Variant* , 1996, The Journal of Biological Chemistry.
[106] M. Coulthard,et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. , 1996, The New England journal of medicine.
[107] W. Müller-Esterl,et al. Palmitoylation of Endothelin Receptor A , 1996, The Journal of Biological Chemistry.
[108] Marc Parmentier,et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.
[109] H. Hwu,et al. No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients. , 1996, American journal of medical genetics.
[110] Michel Bouvier,et al. A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.
[111] G. Tsujimoto,et al. α1a‐Adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy , 1996 .
[112] A. Helenius,et al. Glycan-dependent and -independent Association of Vesicular Stomatitis Virus G Protein with Calnexin* , 1996, The Journal of Biological Chemistry.
[113] S. Liggett,et al. Chimeric Mutagenesis of Putative G-protein Coupling Domains of the α2A-Adrenergic Receptor , 1996, The Journal of Biological Chemistry.
[114] K. Kidd,et al. The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus , 1996, Human Genetics.
[115] Michael G. Davis,et al. Mutagenic Analysis of Platelet Thromboxane Receptor Cysteines , 1996, The Journal of Biological Chemistry.
[116] P. Puri,et al. Novel mutations of the endothelin-B receptor gene in isolated patients with Hirschsprung's disease. , 1996, Human molecular genetics.
[117] V. Chhajlani,et al. Identification of ligand binding residues in extracellular loops of the melanocortin 1 receptor. , 1996, Biochemical and biophysical research communications.
[118] P. Seeman,et al. Dopamine D4 receptor variant in Africans, D4valine194glycine, is insensitive to dopamine and clozapine: report of a homozygous individual. , 1996, American journal of medical genetics.
[119] G. Tsujimoto,et al. Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy. , 1996, British journal of pharmacology.
[120] S. Liggett,et al. Chimeric mutagenesis of putative G-protein coupling domains of the alpha2A-adrenergic receptor. Localization of two redundant and fully competent gi coupling domains. , 1996, The Journal of biological chemistry.
[121] S. Pearce,et al. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. , 1995, The Journal of clinical investigation.
[122] Y. Mori,et al. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus. , 1995, The Journal of clinical investigation.
[123] S. Daiger,et al. Correlation of phenotype with genotype in inherited retinal degeneration , 1995 .
[124] M. J. Arranz,et al. Association between clozapine response and allelic variation in 5-HT2A receptor gene , 1995, The Lancet.
[125] D. Goldman,et al. Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C). , 1995, Genomics.
[126] S. Green,et al. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. , 1995, The Journal of clinical investigation.
[127] E. Mariman,et al. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene , 1995, Nature Genetics.
[128] J. Dimsdale,et al. Racial Differences in Epinephrine and β2-Adrenergic Receptors , 1995 .
[129] J. Dimsdale,et al. Racial differences in epinephrine and beta 2-adrenergic receptors. , 1995, Hypertension.
[130] Masashi Yanagisawa,et al. A missense mutation of the endothelin-B receptor gene in multigenic hirschsprung's disease , 1994, Cell.
[131] S. Higuchi,et al. Association of structural polymorphism of the dopamine D2 receptor gene and alcoholism. , 1994, Biochemical and biophysical research communications.
[132] R. Clark,et al. cAMP-dependent protein kinase and protein kinase C consensus site mutations of the beta-adrenergic receptor. Effect on desensitization and stimulation of adenylylcyclase. , 1994, The Journal of biological chemistry.
[133] S. Green,et al. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. , 1994, Biochemistry.
[134] L. Tiret,et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. , 1994, Hypertension.
[135] D. Bichet,et al. Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant. , 1994, Cellular and molecular biology.
[136] R. Lefkowitz,et al. A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[137] M. Itokawa,et al. Association of dopamine D2 receptor molecular variant with schizophrenia , 1994, The Lancet.
[138] Hongtao Yu,et al. Structural basis for the binding of proline-rich peptides to SH3 domains , 1994, Cell.
[139] R. Graham,et al. The high affinity state of the beta 2-adrenergic receptor requires unique interaction between conserved and non-conserved extracellular loop cysteines. , 1994, The Journal of biological chemistry.
[140] E. El-Fakahany,et al. An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor. , 1994, Molecular pharmacology.
[141] L. Birnbaumer,et al. Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation. , 1994, Molecular pharmacology.
[142] B. Kobilka,et al. The peptide product of a 5' leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis. , 1994, The Journal of biological chemistry.
[143] K. Blum,et al. No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. , 1994, JAMA.
[144] R. Lefkowitz,et al. Erratum: Constitutively active mutants of the α2-adrenergic receptor (Journal of Biological Chemistry (1993) 268 (16483-16487)) , 1994 .
[145] C. M. Davenport,et al. Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain. , 1993, The Journal of biological chemistry.
[146] M. Itokawa,et al. A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys). , 1993, Biochemical and biophysical research communications.
[147] R. Cotton,et al. A new codon 15 rhodopsin gene mutation in autosomal dominant retinitis pigmentosa is associated with sectorial disease. , 1993, Archives of ophthalmology.
[148] J. Kleinman,et al. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. , 1993, Archives of general psychiatry.
[149] R. Lefkowitz,et al. Constitutively active mutants of the alpha 2-adrenergic receptor. , 1993, The Journal of biological chemistry.
[150] J. Ott,et al. Molecular analysis and genetic mapping of the rhodopsin gene in families with autosomal dominant retinitis pigmentosa. , 1993, Genomics.
[151] J. Wess,et al. Functional role of proline and tryptophan residues highly conserved among G protein‐coupled receptors studied by mutational analysis of the m3 muscarinic receptor. , 1993, The EMBO journal.
[152] R Pickens,et al. Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. , 1992, Archives of general psychiatry.
[153] C. Fraser,et al. Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor. Role of conserved cysteines in receptor function. , 1992, The Journal of biological chemistry.
[154] M. Caron,et al. Discrete amino acid sequences of the alpha 1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis. , 1992, The Journal of biological chemistry.
[155] M. Caron,et al. Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. , 1992, The Journal of biological chemistry.
[156] D. Rutledge. Are There Beta-Adrenergic Receptor Response Differences between Racial Groups? , 1991, DICP : the annals of pharmacotherapy.
[157] Philip Seeman,et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine , 1991, Nature.
[158] K. Blum,et al. Allelic association of human dopamine D2 receptor gene in alcoholism. , 1990, JAMA.
[159] D. Grandy,et al. Cloning of the cDNA and gene for a human D2 dopamine receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[160] M. Caron,et al. Removal of phosphorylation sites from the β2-adrenergic receptor delays onset of agonist-promoted desensitization , 1988, Nature.
[161] C. Malbon,et al. N-glycosylation in expression and function of beta-adrenergic receptors. , 1986, The Journal of biological chemistry.